A family of parasite proteins could be a promising new malaria drug target. Over 200 million people contract malaria every year; while treatments are available, growing drug resistance remains a ...

Australian researchers have visualized a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from ...

Australian researchers have found a new drug target for stopping the spread of malaria, after successfully blocking the world's deadliest malaria parasite - Plasmodium falciparum - from completing the ...

A team at Portland State University is leading research on a new drug showing promise to treat one of the deadliest diseases ...

Scientists have discovered the role of the protein EphA2 in causing blood–brain barrier disruption in cerebral malaria, suggesting the protein could act as a potential drug target. Worldwide, cerebral ...

A depiction of proteins Pfs230 and Pfs48/45 bound together. This binding process is crucial for the malaria parasite’s ability to fertilise and spread. Australian researchers have visualised a key ...

Malaria, caused by a parasite transmitted to humans through an infected mosquito's bite, is a leading cause of illness and death worldwide. Most susceptible are pregnant women, displaced people and ...

A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of ...